基金业绩
基金费率
投资组合
- 十大重仓股
- 持仓重大变化
- 全部持股
- 持有债券
- 资产配置
基金概况
财务数据
广发中证香港创新药(QDII-ETF)(513120)
2026-01-30
1.2801
-2.4314%
| 报告期 |
基金净值 |
股票 |
国债及现金 |
可转债 |
企业债 |
金融债 |
其他债券 |
其他投资 |
贷方余额 |
| 2025-12-31 | 2,340,343.71 | 2,309,965.12 | 47,516.39 | 0.00 | 0.00 | 0.00 | 0.00 | 27.60 | 0.00 |
| 2025-09-30 | 2,488,880.77 | 2,455,425.85 | 53,041.33 | 0.00 | 0.00 | 0.00 | 0.00 | 25,103.92 | 0.00 |
| 2025-06-30 | 1,342,413.50 | 1,308,050.43 | 50,264.94 | 0.00 | 0.00 | 0.00 | 0.00 | 1,815.83 | 0.00 |
| 2025-03-31 | 1,045,640.13 | 1,045,723.22 | 54,785.72 | 0.00 | 0.00 | 0.00 | 0.00 | 27,507.85 | 0.00 |
| 2024-12-31 | 787,525.86 | 766,098.47 | 49,191.74 | 0.00 | 0.00 | 0.00 | 0.00 | 63.72 | 0.00 |
| 2024-09-30 | 681,238.81 | 662,295.41 | 31,006.91 | 0.00 | 0.00 | 0.00 | 0.00 | 8,004.97 | 0.00 |
| 2024-06-30 | 495,521.05 | 484,565.33 | 15,405.72 | 0.00 | 0.00 | 0.00 | 0.00 | 1,631.86 | 0.00 |
| 2024-03-31 | 575,842.99 | 562,941.73 | 21,857.37 | 0.00 | 0.00 | 0.00 | 0.00 | 25.73 | 0.00 |
| 2023-12-31 | 678,070.76 | 669,951.96 | 20,051.98 | 0.00 | 0.00 | 0.00 | 0.00 | 3,524.82 | 0.00 |
| 2023-09-30 | 406,615.71 | 398,781.79 | 13,146.54 | 0.00 | 0.00 | 0.00 | 0.00 | 960.34 | 0.00 |
| 2023-06-30 | 248,439.20 | 243,901.22 | 7,038.92 | 0.00 | 0.00 | 0.00 | 0.00 | 434.10 | 0.00 |
| 2023-03-31 | 51,240.06 | 50,058.00 | 2,029.16 | 0.00 | 0.00 | 0.00 | 0.00 | 17.25 | 0.00 |
| 2022-12-31 | 18,487.75 | 18,245.80 | 257.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 2022-09-30 | 10,905.16 | 10,750.35 | 142.84 | 0.00 | 0.00 | 0.00 | 0.00 | 22.56 | 0.00 |
| 2022-07-05 | 30,023.90 | 4,131.75 | 30,015.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 | 0.00 |
